Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

4.1K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.1K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.0K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.0K
Long-term Potentiation01:35

Long-term Potentiation

57.2K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
57.2K
Long-term Potentiation01:25

Long-term Potentiation

3.1K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.1K
Turnover Number and Catalytic Efficiency01:19

Turnover Number and Catalytic Efficiency

18.4K
The turnover number of an enzyme is the maximum number of substrate molecules it can transform per unit time. Turnover numbers for most enzymes range from 1 to 1000 molecules per second. Catalase has the known highest turnover number, capable of converting up to 2.8×106 molecules of hydrogen peroxide into water and oxygen per second. Lysozyme has the lowest known turnover number of half a molecule per second.
Chymotrypsin is a pancreatic enzyme that breaks down proteins during digestion....
18.4K
Generation Time01:22

Generation Time

1000
Bacterial generation time, the period required for a bacterial population to double during its exponential growth phase, serves as a critical measure of microbial growth dynamics under optimal conditions. This parameter varies significantly across bacterial species and can be influenced by factors such as temperature, pH, and the availability of nutrients. For example, Escherichia coli can achieve a generation time of approximately 20 minutes, while Mycobacterium tuberculosis exhibits a much...
1000

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Journal of Clinical Pharmacology: 65 Years of History.

Journal of clinical pharmacology·2026
Same author

Steroid Hormone Changes after Short-Term High-Dose Exposure to Cannabidiol in Healthy Subjects: An Exploratory Study.

Medical cannabis and cannabinoids·2026
Same author

Question: Why Is My Patient With Breast Cancer Advised That She Can Take Clozapine and Tamoxifen Together Despite Possible Interactions Between the Two?

Journal of clinical psychopharmacology·2026
Same author

Volume of distribution in pharmacokinetics and clinical medicine: a critical update.

The Journal of pharmacy and pharmacology·2026
Same author

Karl Rickels, MD: A 100-Year Journey.

Journal of clinical psychopharmacology·2026
Same author

Time Trends in Prescribing of Anxiolytic, Sedative, and Hypnotic Drugs in the United States.

Clinical therapeutics·2026
Same journal

Beyond the "Undruggable": What Pancreatic Cancer Teaches Us About the Next Evolution of Clinical Pharmacology.

Clinical pharmacology in drug development·2026
Same journal

Comparison of ABBV-552 Safety and Pharmacokinetics in Healthy Asian and Western Adults.

Clinical pharmacology in drug development·2026
Same journal

Bioequivalence of a Fixed-Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open-Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting Conditions.

Clinical pharmacology in drug development·2026
Same journal

A Phase 1 Study to Assess the Relative Bioavailability of Brigatinib Administered as an Oral Solution Versus an Immediate-Release Tablet in Healthy Adults.

Clinical pharmacology in drug development·2026
Same journal

Population Pharmacokinetic-Based Meropenem Dosing in Critically and Non-Critically Ill Patients with Mixed Gram-Negative Bacterial Infections.

Clinical pharmacology in drug development·2026
Same journal

Effect of High-Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric-Coated Capsules in Healthy Chinese Subjects.

Clinical pharmacology in drug development·2026
See all related articles

Related Experiment Video

Updated: Nov 22, 2025

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System
08:59

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

Published on: May 22, 2020

5.8K

Starting the Tenth Year

David J Greenblatt

    Clinical Pharmacology in Drug Development
    |January 7, 2021
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Protocol to Acquire the Degenerative Tenocyte from Humans
    09:25

    A Protocol to Acquire the Degenerative Tenocyte from Humans

    Published on: June 9, 2018

    7.6K
    Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study
    09:36

    Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study

    Published on: June 6, 2025

    386

    Related Experiment Videos

    Last Updated: Nov 22, 2025

    Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System
    08:59

    Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

    Published on: May 22, 2020

    5.8K
    A Protocol to Acquire the Degenerative Tenocyte from Humans
    09:25

    A Protocol to Acquire the Degenerative Tenocyte from Humans

    Published on: June 9, 2018

    7.6K
    Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study
    09:36

    Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study

    Published on: June 6, 2025

    386